COCH
Envoy Medical, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.71
−2.75%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.6x
Market Cap
$54.95M
MomentumView details →
1D Return
−2.75%
YTD Return
+9.98%
RSI (14)
51.4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.6x
Market Cap
$54.95M
RSI (14)
51.4
MomentumView details →
1D Return
−2.75%
YTD Return
+9.98%
SummaryUpdated Jun 1, 2026
Envoy Medical, Inc. (NASDAQ:COCH) is a hearing health company founded in 1995 and headquartered in White Bear Lake, Minnesota. Originally established as St. Croix Medical, Inc., the company changed its name to Envoy Medical Corporation in December 2004 before becoming Envoy Medical, Inc. The company went public in April 2021 and develops medical technologies designed to address various forms of hearing loss across the hearing loss spectrum.
Similar companies
Latest newsMore news →
Envoy Medical, Inc. appointed Robert Potashnick as Chief Accounting Officer and Vice President of Finance, effective August 24, 2026.9d agoEnvoy Medical reported financial results for the second quarter ended June 30, 2026, on August 10, 2026.25d agoEnvoy Medical announced that all 56 patients in its pivotal clinical trial for the Acclaim cochlear implant have passed the three-month visit milestone.45d ago